Mometasone Teva (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors in nasal mucosal cells, altering gene expression to suppress inflammatory cytokines, decrease vascular permeability, and inhibit immune cell migration, which together reduce swelling and irritation in the nasal passages.

The appropriate dose of Mometasone Teva is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for mometasone furoate in pregnancy are limited, so it should be used only if the potential benefit justifies any potential risk. During breastfeeding, use only if the benefit to the mother outweighs possible risks to the infant, and consult a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mometasone Teva offers a high‑potency glucocorticoid with once‑daily dosing, which can provide effective symptom control with a low systemic exposure compared with some older nasal steroids. Clinical choice depends on individual response, tolerability, and prescriber preference.

Store the nasal spray at room temperature, below 25 °C. Keep it in the original packaging, protect it from moisture and direct heat, and ensure the cap is tightly closed to maintain product stability.

Mometasone Teva is administered as a nasal spray. The patient tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks include nasal septal perforation, severe allergic reactions such as anaphylaxis, adrenal suppression with prolonged high‑dose use, and rare ocular effects like cataracts or glaucoma. Patients should report any unusual symptoms to their healthcare provider promptly.

Mometasone Teva should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation, and it is not recommended for patients with active untreated nasal infections or recent nasal surgery without medical advice.